Neutralizing Antibody and T-Cell Responses against SARS-CoV-2 Wild-Type and Variants of Concern in Chronic Obstructive Pulmonary Disease Subjects after ChAdOx-1/ChAdOx-1 Homologous Vaccination: A Preliminary Study

Chaiwong, W; Takheaw, N; Laopajon, W; Pata, S; Duangjit, P; Inchai, J; Pothirat, C; Bumroongkit, C; Deesomchok, A; Theerakittikul, T; Limsukon, A; Tajarernmuang, P; Niyatiwatchanchai, N; Trongtrakul, K; Chuensirikulchai, K; Cheyasawan, P; Liwsrisakun, C; Kasinrerk, W

Liwsrisakun, C (通讯作者),Chiang Mai Univ, Fac Med, Dept Internal Med, Div Pulm Crit Care & Allergy, Chiang Mai 50200, Thailand.;Kasinrerk, W (通讯作者),Chiang Mai Univ, Fac Associated Med Sci, Dept Med Technol, Div Clin Immunol, Chiang Mai 50200, Thailand.;Kasinrerk, W (通讯作者),Chiang Mai Univ, Fac Associated Med Sci, Biomed Technol Res Ctr, Natl Ctr Genet Engn & Biotechnol ,Natl Sci & Techn, Chiang Mai 50200, Thailand.

VACCINES, 2022; 10 (12):

Abstract

Data on immunogenicity of adenovirus-vectored vaccine in chronic obstructive pulmonary disease (COPD) patients is limited. Therefore, we aimed to dete......

Full Text Link